Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,431 | -47,809 | -25,260 | 808 | -146,427 |
| Depreciation Amortization | 35,057 | 26,265 | 16,991 | 8,345 | 55,023 |
| Accounts receivable | 2,301 | 3,195 | 3,979 | -61 | -5,184 |
| Accounts payable and accrued liabilities | -6,036 | -10,213 | -16,407 | -16,577 | 9,255 |
| Other Working Capital | -26,042 | -24,936 | -34,721 | -36,237 | 2,624 |
| Other Operating Activity | 121,408 | 24,625 | 19,810 | 14,567 | 26,495 |
| Operating Cash Flow | $-42,743 | $-28,873 | $-35,608 | $-29,155 | $-58,214 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 58,518 | 80,149 | 116,403 | 44,165 | 35,428 |
| PPE Investments | -6,767 | -2,926 | -518 | -208 | -195 |
| Purchase Sale Intangibles | -17,799 | -13,039 | -8,532 | -4,406 | -15,370 |
| Other Investing Activity | -113,078 | -13,039 | -8,532 | -4,406 | -15,370 |
| Investing Cash Flow | $-61,327 | $64,184 | $107,353 | $39,551 | $19,863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 135,415 | 110,037 | 109,075 | 60 | 1,618 |
| Other Financing Activity | -7,702 | -7,363 | -6,053 | -5,833 | -3,695 |
| Financing Cash Flow | $127,713 | $102,674 | $103,022 | $-5,773 | $-2,077 |
| Exchange Rate Effect | -1,307 | 60 | -33 | -40 | -9 |
| Beginning Cash Position | 62,436 | 62,436 | 62,436 | 62,436 | 102,873 |
| End Cash Position | 84,772 | 200,481 | 237,170 | 67,019 | 62,436 |
| Net Cash Flow | $22,336 | $138,045 | $174,734 | $4,583 | $-40,437 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,743 | -28,873 | -35,608 | -29,155 | -58,214 |
| Capital Expenditure | -6,767 | -2,926 | -518 | -208 | -195 |
| Free Cash Flow | -49,510 | -31,799 | -36,126 | -29,363 | -58,409 |